Vimarsana
Biggest News Aggregation in the World

Walter Strapps News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Walter Strapps. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Walter Strapps Today - Breaking & Trending Today

Liberate Bio taps former AZ drug-delivery head for CEO post - Vimarsana News

Liberate Bio taps former AZ drug-delivery head for CEO post

C-suite additions at Boston-based Liberate Bio also include the appointment of a new chief scientific officer.

David Regan of Sona Nanotech provides an update on its agreement with Siva Therapeutics to develop cancer treating therapies - Vimarsana News

David Regan of Sona Nanotech provides an update on its agreement with Siva Therapeutics to develop cancer treating therapies

David Regan provides an update on Sona Nanotech’s agreement with Siva Therapeutics to develop gold nanorod therapies for treating cancer

Carver Biosciences Raises Seed Financing - Vimarsana News

Carver Biosciences Raises Seed Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Sona Nanotech Inc.: Sona Announces Appointment of Two New Directors, Debt Settlement and Option Grant - Vimarsana News

Sona Nanotech Inc.: Sona Announces Appointment of Two New Directors, Debt Settlement and Option Grant

This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 9, 2021 to its short form base prospectus dated March 31, 2021 Halifax, Nova

Chutes & Ladders—Pfizer's development leader is retiring in early 2022 - Vimarsana News

Chutes & Ladders—Pfizer's development leader is retiring in early 2022

Pfizer's chief development officer, Rod MacKenzie, is the Big Pharma's second executive to retire in early 2022. NIH Director Francis Collins will also hit the exit, before the end of this year. Sanofi poaches Gilead cancer executive Valeria Fantin to run its oncology research.